Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2899 Target Snapshot

Adenylate cyclase type 1 · SINGLE PROTEIN · Homo sapiens

212Compounds
27Assays
0Approved Drugs
284.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q08828. Use UniProt Q08828 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q08828 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Adenylate cyclase type 1 as ChEMBL target CHEMBL2899, mapped to UniProt Q08828. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Adenylate cyclase type 1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2899
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q08828
Adenylate cyclase type 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Adenylate cyclase type 1 is the right protein anchor across sources, using UniProt Q08828 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAdenylate cyclase type 1
UniProt AccessionQ08828
Component TypeProtein
Sequence Length1119 aa

Adenylate cyclase type 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Adenylate cyclase type 1, mapped to UniProt Q08828. Sequence length is 1119 aa.

Mapped IDQ08828
Review nameAdenylate cyclase type 1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC50195.0
KI1.0
EC5088.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL328689 7.68 IC50 21.0 Preclinical
CHEMBL328561 7.51 IC50 31.0 Preclinical
CHEMBL92229 7.5 IC50 32.0 Preclinical
CHEMBL329247 7.44 IC50 36.0 Preclinical
CHEMBL93009 7.41 IC50 39.0 Preclinical
CHEMBL52606 7.39 IC50 41.0 Clinical
CHEMBL317990 7.37 IC50 43.0 Preclinical
CHEMBL432817 7.36 IC50 44.0 Preclinical
CHEMBL93242 7.19 IC50 64.0 Preclinical
CHEMBL93259 7.19 IC50 65.0 Preclinical
Distribution

pChEMBL Value Distribution

54
5.0
38
5.5
36
6.0
25
6.5
13
7.0
3
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

27
Total Assays
146
Tested Compounds
3
Assay Types
Binding — 16 assays, 146 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 10 101 5.4
assay format 3 45 6.9
cell membrane format 2 0
single protein format 1 0
Functional — 10 assays, 44 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 8 44 5.7
cell membrane format 2 0
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine